 | • レポートコード：TPM-B04580 • 出版社/出版日：Transparency Market Research / 2018年3月29日 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、老年医学の世界市場について調べ、老年医学の世界規模、市場動向、市場環境、治療薬分類別（鎮痛剤、降圧剤、スタチン、抗糖尿病薬、プロトンポンプ阻害剤、抗凝固剤、抗精神病薬、抗鬱剤、その他）分析、症状別（心血管疾患、関節炎、癌、骨粗鬆症、呼吸器系、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・老年医学の世界市場動向 ・老年医学の世界市場環境 ・老年医学の世界市場規模 ・老年医学の世界市場規模：治療薬分類別（鎮痛剤、降圧剤、スタチン、抗糖尿病薬、プロトンポンプ阻害剤、抗凝固剤、抗精神病薬、抗鬱剤、その他） ・老年医学の世界市場規模：症状別（心血管疾患、関節炎、癌、骨粗鬆症、呼吸器系、その他） ・老年医学の世界市場：地域別市場規模・分析 ・老年医学の北米市場規模・予測 ・老年医学のアメリカ市場規模・予測 ・老年医学の中南米市場規模・予測 ・老年医学のヨーロッパ市場規模・予測 ・老年医学のアジア市場規模・予測 ・競争状況・関連企業情報 |
Global Geriatric Medicine Market: Overview
This report on the global geriatric medicine market is a comprehensive assessment of how the demand has progressed in the recent past and where it is headed in the near future. Developed by experienced and professional research analyst, the report aspires to serve as a credible business tool for its targeted audiences such as pharmaceutical companies, drug research and development institutes, suppliers and distributors of pharmaceuticals, and government agencies.
This report provides in-depth analysis of the global geriatric medicines market. The stakeholders for this report include companies involved in the research and development, manufacturing and commercialization of geriatric medicines, suppliers, and new entrants planning to invest in this market. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends, and competition for different geriatric medicines in the major five regions.
Global Geriatric Medicine Market: Key Research Aspects
This research study analyzes the market for geriatric medicine market in terms of revenue (US$ Mn). For the research, 2016 has been considered as the base year, while all forecasts have been provided from 2017 to 2023. The global geriatric medicine market has been broadly segmented on the basis of condition (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory and Others), therapeutic category (Analgesic, Antihypertensive, Statins, Antidiabetic, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, antidepressant and others), and geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).
The market overview section of this report analyzes market dynamics such as drivers, restraints, and opportunities that influence the geriatric medicines market in the current and future scenario. Furthermore, the market attractiveness analysis and pipeline analysis has been included in market overview section in order to explain the intensity of competition in the market. Competitive scenario among the market players is analyzed through a heat map of major market players in the competitive landscape section of the report. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in the global market.
Global Geriatric Medicine Market: Competitive Landscape
This report also includes recommendations section that will assist new companies in establishing their presence and market players in expanding their market share in the geriatric medicines market. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies, and recent developments for market players. Some of the prominent players in geriatric medicines market include Abbott Laboratories, Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc., Merck & Company Inc., Novartis AG, Pfizer, Inc., Sanofi S.A.
Global Geriatric Medicines Market, by Therapeutic Category
Analgesic
Antihypertensive
Statins
Antidiabetic
PPI
Anticoagulant
Antipsychotic
Others
Global Geriatric Medicines Market, by Condition
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Others
Global Geriatric Medicines Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Rest of LATAM
Middle East and Africa
South Africa
Rest of MEA
1. Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
2. Executive Summary
2.1. Global Geriatric Medicines Market, by Geography, 2014 & 2023 (Value %)
2.2. Global Geriatric Medicines Market, by Therapeutic Category, 2014 (US$ Mn)
2.3. Geriatric Medicines Market Snapshot
3. Global Geriatric Medicines Market – Industry Analysis
3.1. Introduction
3.2. Market Drivers
3.2.1. Rise in Chronis Diseases
3.2.2. Increase in Government support
3.3. Restraints
3.3.1. Lack of Patient Participation in Clinical Trials
3.4. Opportunity
3.4.1. Asia Pacific Holds Immense Potential for Geriatric Medicines
3.5. Pipeline Analysis (Phase III Drug Candidate)
3.6. Market Attractiveness Analysis– Geriatric Medicines Market, by Geography (2014) (%)
3.7. Heat Map Analysis, by Key Players, 2014
4. Market Segmentation – By Therapeutic Category
4.1. Introduction
4.2. Global Geriatric Medicines Market Revenue, by Therapeutic Category, 2013–2023 (US$ Mn)
4.3. Global Analgesic Market Revenue, 2013–2023 (US$ Mn)
4.4. Global Antihypertensive Market Revenue, 2013–2023 (US$ Mn)
4.5. Global Statins Market Revenue, 2013–2023 (US$ Mn)
4.6. Global Antidiabetic Market Revenue, 2013–2023 (US$ Mn)
4.7. Global PPI Market Revenue, 2013–2023 (US$ Mn)
4.8. Global Anticoagulant Market Revenue, 2013–2023 (US$ Mn)
4.9. Global Antipsychotic Market Revenue, 2013–2023 (US$ Mn)
4.10. Global Others Market Revenue, 2013–2023 (US$ Mn)
5. Market Segmentation – By Condition
5.1. Introduction
5.2. Global Geriatric Medicines Market Revenue, by Condition, 2013–2023 (US$ Mn)
5.3. Global Cardiovascular Market Revenue, 2013–2023 (US$ Mn)
5.4. Global Arthritis Market Revenue, 2013–2023 (US$ Mn)
5.5. Global Neurological Market Revenue, 2013–2023 (US$ Mn)
5.6. Global Cancer Market Revenue, 2013–2023 (US$ Mn)
5.7. Global Osteoporosis Market Revenue, 2013–2023 (US$ Mn)
5.8. Global Respiratory Market Revenue, 2013–2023 (US$ Mn)
5.9. Global Others Market Revenue, 2013–2023 (US$ Mn)
6. Market Segmentation – By Geography
6.1. Introduction
6.2. Global Geriatric Medicines Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.3. North America Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
6.4. Europe Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
6.5. Asia Pacific Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
6.6. Latin America Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
6.7. MEA Geriatric Medicines Market Revenue, by Country, 2013–2023,0020(US$ Mn)
7. Recommendations
8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.2. AstraZeneca plc
8.3. Boehringer Ingelheim GmbH
8.4. Bristol-Myers Squibb Company
8.5. Eli Lilly and Company
8.6. GlaxoSmithKline Plc.
8.7. Merck & Company Inc.
8.8. Novartis AG
8.9. Pfizer, Inc.
8.10. Sanofi S.A